2m 2m 2m 2m 2m 2m 2m
Kura Oncology (KURA)
NASDAQ
$10.30-$0.06 (-0.58%)
Price as of Jun 23, 2026 6:55 PM EDT- $919.7MMarket Cap
- 76.49%1-Year Change
- BiotechnologyIndustry
Kura Oncology (KURA)
$10.30-$0.06 (-0.58%)
KURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.36 | ||
Change | +$0.43 (+4.33%) | ||
Open | $9.96 | ||
High | $10.54 | ||
Low | $9.95 | ||
Previous Close | $9.93 | ||
Volume | 1,386,198 | ||
30-Day Average Volume | 1,881,603 | ||
1-Week Change | 8.60% | ||
1-Month Change | -7.91% | ||
1-Year Change | 76.49% | ||
3-Year Change | -4.60% | ||
5-Year Change | -51.90% | ||
Fundamentals | |||
Shares Outstanding | 88.8M | ||
Total Assets | $652.6M | ||
Market Cap | $919.7M | ||
Enterprise Value | $890.4M | ||
Period: QTR TTM FY | |||
Revenue | $5.8M | ||
Net Income | -$73.3M | ||
Free Cash Flow | -$86.0M | ||
EBIT | -$73.3M | ||
EBITDA | -$73.0M | ||
Net Working Capital | $522.3M | ||
EPS | -$0.83 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 154 | ||
P/B | 9 | ||
P/E | -12 | ||
PEG | -1 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue